<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-10">
 <label>10</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Young</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Collins</surname>
    <given-names>PW</given-names>
   </name>
   <name>
    <surname>Colberg</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4).</article-title>
  <source>
   <italic>Thromb Res.</italic>
  </source>
  <year>2016</year>;
  <volume>141</volume>:
  <fpage>69</fpage>–
  <lpage>76</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.thromres.2016.02.030</pub-id>
  <?supplied-pmid 26970716?>
  <pub-id pub-id-type="pmid">26970716</pub-id>
 </mixed-citation>
 <note>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://f1000.com/prime/726331501" xmlns:xlink="http://www.w3.org/1999/xlink">F1000 Recommendation</ext-link>
  </p>
 </note>
</ref>
